It would also explain some of the altered morphology in Down syndrome (with increased DYRK1A gene dosage) characterised by thicker retinas and altered visuo-cortical processing as observed by visual evoked potential (VEP) testing [58,59]. This evidence concerns the gene DYRK1A and Down syndrome.